Pharmacyclics

Pharmacyclics is a pharmaceutical company developing innovative treatments for cancer and other diseases. The company is working on a range of clinical and laboratory programs and is pursuing the development of novel drugs aimed at specific disease pathways. The company's most advanced product candidate, Xcytrin®(motexafin gadolinium) is a rationally designed small molecule, the first in a class of drugs that concentrates in cancer cells and disr... more
top ↑

Facts from the Community

From the BioVenturist base

Medical focus:

From the business2 base

Operating Income:

Currency Amount Valid Date
  • -22,430,000
  • Jun 30, 2009

Net profit:

Currency Amount Valid Date
  • -23,450,000
  • Jun 30, 2009

Cash:

Currency Amount Valid Date
  • 14,530,000
  • Jun 30, 2009

Current Assets:

Currency Amount Valid Date
  • 17,540,000
  • Jun 30, 2009

Total Assets:

Currency Amount Valid Date
  • 18,300,000
  • Jun 30, 2009

Current Liabilities:

Currency Amount Valid Date
  • 15,370,000
  • Jun 30, 2009

Total Liabilities:

Currency Amount Valid Date
  • 20,040,000
  • Jun 30, 2009

Retained Earnings:

Currency Amount Valid Date
  • -362,900,000
  • Jun 30, 2009
top ↑

We can also tell you Pharmacyclics is a…

If you know more about Pharmacyclics, you can add more facts here »

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

Learn more about Freebase licensing and attribution